论文信息 - Sorafenib is a potent inhibitor of FIP1L1-PDGFRα and the imatinib-resistant FIP1L1-PDGFRα T674I mutant - 字舞流文

Sorafenib is a potent inhibitor of FIP1L1-PDGFRα and the imatinib-resistant FIP1L1-PDGFRα T674I mutant

P. Marynen | J. Cools | N. Mentens | P. Vandenberghe | M. Boogaerts | E. Stover | E. Lierman | C. Folens | W. Scheers | Helen van Miegroet | Els Lierman | Cedric Folens